Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

Not everyone responds to statins, the standard treatment for people at risk of cardiovascular disease, so an alternative ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

In August 2022, T-Mobile and SpaceX announced a bold plan to expand cellular connectivity across the US with the help of low-orbit satellites. Fast-forward to 2025, and the T-Mobile Starlink ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based ...

T-Mobile is one of the fastest-growing carriers in the United States thanks to aggressive pricing, marketing, and a penchant for doing the unexpected. The Uncarrier has significantly shaken up the ...

Many cells in multicellular organisms are specialised. They have specific roles in the organism of which they are part. Their structure is adapted to their function. They are often grouped ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

Oxide-ion conductors are important energy materials. Here, the authors found a tellurite-based oxygen ion conductor highlighting the interplay of secondary bond interactions and Grotthuss-like ...